Key points from article :
Qubit Pharmaceuticals raised €16.1 million in a seed round.
Funds will be used to add 40 more people to the team and to continue to invest in quantum computing.
Classical computing makes pharmaceutical research expensive and time-consuming.
Qubit's platform called ATLAS is a software suite for the discovery and test of drug candidates running on supercomputers.
"We have launched 3 research programs on Covid-19, cancer and inflammation, and we want to launch ten," - Robert Marino, Qubit Pharmaceutical’s CEO.
Working to leverage the powers of early stage quantum computers and supercomputers to boost the discovery of new drugs.
